Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Spatial frequency analysis of anisotropic drug transport in tumor samples.

Russell S, Samkoe KS, Gunn JR, Hoopes PJ, Nguyen TA, Russell MJ, Alfano RR, Pogue BW.

J Biomed Opt. 2014 Jan;19(1):15005. doi: 10.1117/1.JBO.19.1.015005.

2.

Spatial frequency analysis of high-density lipoprotein and iron-oxide nanoparticle transmission electron microscope image structure for pattern recognition in heterogeneous fields.

Russell S, Nguyen TA, Torres CR, Bhagroo S, Russell MJ, Alfano RR.

J Biomed Opt. 2014 Jan;19(1):15004. doi: 10.1117/1.JBO.19.1.015004.

PMID:
24390373
3.

Intratumoral drug delivery with nanoparticulate carriers.

Holback H, Yeo Y.

Pharm Res. 2011 Aug;28(8):1819-30. doi: 10.1007/s11095-010-0360-y. Epub 2011 Jan 7. Review.

4.

Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.

Jiao Y, Sun Y, Tang X, Ren Q, Yang W.

Small. 2015 Apr 24;11(16):1962-74. doi: 10.1002/smll.201402297. Epub 2014 Dec 12.

PMID:
25504837
5.

Drug delivery and transport to solid tumors.

Jang SH, Wientjes MG, Lu D, Au JL.

Pharm Res. 2003 Sep;20(9):1337-50. Review.

PMID:
14567626
6.

Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.

Koning GA, Krijger GC.

Anticancer Agents Med Chem. 2007 Jul;7(4):425-40. Review.

PMID:
17630918
7.

Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers.

Lozano MV, Torrecilla D, Torres D, Vidal A, Domínguez F, Alonso MJ.

Biomacromolecules. 2008 Aug;9(8):2186-93. doi: 10.1021/bm800298u. Epub 2008 Jul 19.

PMID:
18637687
8.

Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency.

Sykes EA, Chen J, Zheng G, Chan WC.

ACS Nano. 2014 Jun 24;8(6):5696-706. doi: 10.1021/nn500299p. Epub 2014 May 22.

PMID:
24821383
9.

Dermatan carriers for neovascular transport targeting, deep tumor penetration and improved therapy.

Ranney D, Antich P, Dadey E, Mason R, Kulkarni P, Singh O, Chen H, Constantanescu A, Parkey R.

J Control Release. 2005 Dec 5;109(1-3):222-35. Epub 2005 Nov 14.

PMID:
16290245
10.

Computed tomography-guided time-domain diffuse fluorescence tomography in small animals for localization of cancer biomarkers.

Tichauer KM, Holt RW, Samkoe KS, El-Ghussein F, Gunn JR, Jermyn M, Dehghani H, Leblond F, Pogue BW.

J Vis Exp. 2012 Jul 17;(65):e4050. doi: 10.3791/4050.

11.

Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.

Du JZ, Mao CQ, Yuan YY, Yang XZ, Wang J.

Biotechnol Adv. 2014 Jul-Aug;32(4):789-803. doi: 10.1016/j.biotechadv.2013.08.002. Epub 2013 Aug 7. Review.

PMID:
23933109
12.

Computational methods for predicting drug transport in anisotropic and heterogeneous brain tissue.

Linninger AA, Somayaji MR, Erickson T, Guo X, Penn RD.

J Biomech. 2008 Jul 19;41(10):2176-87. doi: 10.1016/j.jbiomech.2008.04.025. Epub 2008 Jun 11.

PMID:
18550067
13.

Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.

Bhaskar S, Tian F, Stoeger T, Kreyling W, de la Fuente JM, Grazú V, Borm P, Estrada G, Ntziachristos V, Razansky D.

Part Fibre Toxicol. 2010 Mar 3;7:3. doi: 10.1186/1743-8977-7-3. Review.

14.

Tumor physiology and delivery of nanopharmaceuticals.

Campbell RB.

Anticancer Agents Med Chem. 2006 Nov;6(6):503-12. Review.

PMID:
17100555
15.

Role of integrated cancer nanomedicine in overcoming drug resistance.

Iyer AK, Singh A, Ganta S, Amiji MM.

Adv Drug Deliv Rev. 2013 Nov;65(13-14):1784-802. doi: 10.1016/j.addr.2013.07.012. Epub 2013 Jul 21. Review.

PMID:
23880506
16.

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.

Pérez-Herrero E, Fernández-Medarde A.

Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Review.

PMID:
25813885
17.

Analyzing spatiotemporal distribution of uniquely fluorescent nanoparticles in xenograft tumors.

Stirland DL, Matsumoto Y, Toh K, Kataoka K, Bae YH.

J Control Release. 2016 Apr 10;227:38-44. doi: 10.1016/j.jconrel.2016.02.016. Epub 2016 Feb 9.

PMID:
26873335
18.

Nano-engineered mesenchymal stem cells as targeted therapeutic carriers.

Sadhukha T, O'Brien TD, Prabha S.

J Control Release. 2014 Dec 28;196:243-51. doi: 10.1016/j.jconrel.2014.10.015. Epub 2014 Oct 23.

PMID:
25456830
19.

Quantitative study of focused ultrasound enhanced doxorubicin delivery to prostate tumor in vivo with MRI guidance.

Chen X, Cvetkovic D, Ma CM, Chen L.

Med Phys. 2012 May;39(5):2780-6. doi: 10.1118/1.4705346.

PMID:
22559650
20.

Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities.

Kirtane AR, Kalscheuer SM, Panyam J.

Adv Drug Deliv Rev. 2013 Nov;65(13-14):1731-47. doi: 10.1016/j.addr.2013.09.001. Epub 2013 Sep 10. Review.

Supplemental Content

Support Center